Nivien Therapeutics

About:

Nivien Therapeutics is developing the first small molecule drugs to enhance both chemo and immunotherapies.

Website: http://www.nivientherapeutics.com

Twitter/X: NivienTx

Top Investors: IndieBio, SOSV, Third Kind Venture Capital

Description:

Nivien Therapeutics developed the first small molecule inhibitors of the Hippo signaling pathway. Read the Nivien story in The Washington Post: https://www.washingtonpost.com/national/health-science/heres-what-happened-when-i-tried-to-develop-a-new-drug-for-a-deadly-cancer/2019/01/11/

Total Funding Amount:

$600000

Headquarters Location:

San Francisco, California, United States

Founded Date:

2016-01-01

Contact Email:

nbhorwitz(AT)gmail.com

Founders:

Dharmendra Singh, Nathaniel Brooks Horwitz, Nikita Shah, W. Ken Fang

Number of Employees:

1-10

Last Funding Date:

2017-12-01

IPO Status:

Private

Industries: